相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
Jorge Rojas-Serrano et al.
PLOS ONE (2022)
Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study
John E. McKinnon et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021
Jeffrey Lazarus et al.
NATURE COMMUNICATIONS (2022)
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates
Joshua Teperowski Monrad et al.
VACCINE (2022)
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham et al.
CLINICAL INFECTIOUS DISEASES (2021)
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
Benjamin S. Abella et al.
JAMA INTERNAL MEDICINE (2021)
Design of the healthcare worker exposure response and outcomes (HERO) research platform
Anne Friedland et al.
CONTEMPORARY CLINICAL TRIALS (2021)
PCORnet (R) 2020: current state, accomplishments, and future directions
Christopher B. Forrest et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry
Christopher B. Forrest et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Trends in COVID-19 therapeutic clinical trials
Kevin Bugin et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
Berta Grau-Pujol et al.
TRIALS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
Andre C. Kalil
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Characteristics of Health Care Personnel with COVID-19 — United States, February 12–April 9, 2020
et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
Erin K. McCreary et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Using a Single Item to Measure Burnout in Primary Care Staff: A Psychometric Evaluation
Emily D. Dolan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2015)
Item Banks for Measuring Emotional Distress From the Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, Anxiety, and Anger
Paul A. Pilkonis et al.
ASSESSMENT (2011)
Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population
Bruce Arroll et al.
ANNALS OF FAMILY MEDICINE (2010)
Single Item Measures of Emotional Exhaustion and Depersonalization Are Useful for Assessing Burnout in Medical Professionals
Colin P. West et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Validation of a single-item measure of burnout against the Maslach Burnout Inventory among physicians
BM Rohland et al.
STRESS AND HEALTH (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The Patient Health Questionnaire-2 - Validity of a two-item depression screener
K Kroenke et al.
MEDICAL CARE (2003)